Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 01, 2026 04:00 ET | Source: Alvotech

Alvotech further strengthens liquidity by securing term loan facility of $75 million

$75 million additional term loan facility maturing December 31, 2027, led by GoldenTree Asset ManagementFollows recent $165m equity raise strengthening cash positionIncluding equity financing and...
July 01, 2026 04:00 ET | Source: Alvotech

Alvotech styrkir lausafjárstöðu sína enn frekar með aðgengi að 75 milljóna dala lánsfjármögnun

- Hópur fjárfesta undir forystu GoldenTree Asset Management veitir Alvotech viðbótarlán að fjárhæð 75 milljónir dala - Lánveiting kemur í kjölfar nýlegrar hlutafjáraukningar að andvirði 165 milljóna...
July 01, 2026 04:00 ET | Source: Alvotech

Alvotech further strengthens liquidity by securing term loan facility of $75 million

— $75 million additional term loan facility maturing December 31, 2027, led by GoldenTree Asset Management — Follows recent $165m equity raise strengthening cash position — Including equity...
June 22, 2026 18:48 ET | Source: Alvotech

Transactions of Managers and Closely Associated Persons

Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition...
June 22, 2026 18:48 ET | Source: Alvotech

Viðskipti stjórnenda og tengdra aðila

Í viðhengi er tilkynning sem lögð var inn til birtingar hjá fjármálaeftirliti Lúxemborgar, Luxembourg Commission de Surveillance du Secteur Financier (CSSF) varðandi viðskipti stjórnenda og tengdra...
June 18, 2026 05:51 ET | Source: Alvotech

Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement

REYKJAVIK, Iceland, June 18, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture...
June 18, 2026 04:00 ET | Source: Alvotech

Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement

REYKJAVIK, ICELAND (June 18, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar...
June 18, 2026 04:00 ET | Source: Alvotech

Hlutafjárútboði Alvotech í Bandaríkjunum lokið og umsjónaraðilar nýttu sér að fullu kauprétt á viðbótarbréfum svo heildarandvirði að meðtöldum hlutum keyptum af evrópskum fagfjárfestum nemur 165 milljónum dollara

REYKJAVÍK (18. júní 2026) - Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að lokið væri sölutryggðu hlutafjárútboði í Bandaríkjunum. Fjárfestar fengu afhenta þann 17. júní sl. 26.066.667 almenna...
June 15, 2026 23:59 ET | Source: Alvotech

Alvotech Announces Pricing of $152 Million Public Offering of Ordinary Shares and Concurrent Private Placement

REYKJAVIK, Iceland , June 16, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture...
June 15, 2026 23:50 ET | Source: Alvotech

Alvotech Announces Pricing of $152 Million Public Offering of Ordinary Shares and Concurrent Private Placement

REYKJAVIK, ICELAND (June 16, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar...